169276 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
CANCER RISK ASSESSMENT
#2Method for Detecting Alpha Fetoprotein Glycoforms by High Resolution Intact Mass Analysis
#3Agents and methods for treating pancreatic ductal adenocarcinomas
#4AGENTS AND METHODS FOR TREATING PANCREATIC DUCTAL ADENOCARCINOMAS
#5Ultra-high sensitivity dual-gated biosensor based on MOS transistor
#6ONCOFETAL FIBRONECTIN DETECTION METHOD USING SIMPLE IMMUNOASSAY
#7Agents and methods for treating pancreatic ductal adenocarcinomas
#8METHOD FOR DETECTION OF L523S EXPRESSION IN BIOLOGICAL SAMPLES
#9TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN
#10Method for detection of L523S expression in biological samples
#11Methods for detecting oncofetal fibronectin
#12Methods for detecting oncofetal fibronectin
#13Methods and kits for detecting ITA in a biological sample
#14Methods for detecting oncofetal fibronectin
#15Methods and kits for detecting ITA in a biological sample
#16Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody
#17Methods and kits for detecting ITA in a biological sample
#18Method for Detection of L523S Expression in Biological Samples
#19Detection and treatment of cancer
#20Detection of oncofetal fibronectin for selection of concepti
#21Oncofetal fibronectin as a marker for pregnancy-related indications
#22Oncofetal fibronectin as a marker for health and disease
#23Methods for detecting oncofetal fibronectin
#24Samples for detection of oncofetal fibronectin and uses thereof
#25Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
#26Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10